| Dr Jonathan Klarich, MD | |
|
4 Memorial Dr Ste 210, Alton, IL 62002-6704 | |
| (618) 433-6649 | |
| Not Available |
| Full Name | Dr Jonathan Klarich |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 4 Memorial Dr Ste 210, Alton, Illinois |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1609443696 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 125.077904 (Illinois) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jonathan Klarich, MD 1 Memorial Dr Rm G360, Alton, IL 62002-6722 Ph: () - | Dr Jonathan Klarich, MD 4 Memorial Dr Ste 210, Alton, IL 62002-6704 Ph: (618) 433-6649 |
News Archive
How well do you understand sunscreen? For many consumers, the answer is not so well. According to new research, many people are still puzzled by the wide range of SPF numbers on product labels, and some may not be using sunscreen properly, which could increase their skin cancer risk.
Healthcare practitioners can increase the number of patients with heart disease referred to a cardiac rehabilitation program by 40 per cent, helping them to reduce their risk of dying and improve their quality of life, say researchers at the Peter Munk Cardiac Centre.
In a new study of treatment-experienced HIV-1-infected adults with no PREZISTA® (darunavir) resistance-associated mutations (RAMs), 72 percent of patients in the PREZISTA/ritonavir (r) (800/100 mg) once-daily arm achieved undetectable viral loads (<50 copies/mL) compared with 71 percent of patients in the PREZISTA/r (600/100 mg) twice-daily arm. The study met its primary objective of non-inferiority. These data from the Phase 3b ODIN study were presented today at CROI 2010, the 17th Conference on Retroviruses and Opportunistic Infections, in San Francisco.
Elan Corporation, plc and Biogen Idec today announced data showing that treatment with TYSABRI® (natalizumab) significantly reduced the rate of hospitalization compared with placebo in patients with moderate–to–severe Crohn's disease during both induction and maintenance treatment.
One third of women around the world have experienced physical or sexual violence at the hands of their intimate partners with consequences from post-traumatic stress disorder, anxiety, and depression, to sexually transmitted diseases, including HIV.
› Verified 4 days ago
Dr. Juletta Avagyan, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Memorial Dr, Alton, IL 62002 Phone: 618-463-7240 Fax: 618-463-7216 | |
Dr. Bryan Everett Steele, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4 Memorial Dr Ste 210, Alton, IL 62002 Phone: 618-463-5905 Fax: 618-463-5935 | |
Puja Gurung, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4 Memorial Dr Ste 230, Alton, IL 62002 Phone: 618-433-6616 | |
Mr. William P Robinson Jr., MD Family Medicine Medicare: Medicare Enrolled Practice Location: 815 E 5th Street, Suite 209, Alton, IL 62002 Phone: 618-463-0561 Fax: 618-465-9281 | |
Dr. Anne Ugabi, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1 Memorial Dr, Alton, IL 62002 Phone: 618-463-7311 | |
Dr. Danny Sarwat Shehata, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1 Memorial Dr, Alton, IL 62002 Phone: 618-463-7311 | |
Dr. Sisay Michael Abraham, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2 Memorial Dr Ste 220, Alton, IL 62002 Phone: 618-474-1723 |